SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Rep. Richard Neal (D-Mass.) speaks during a news conference in the Capitol Visitor Center on Friday, July 24, 2020. (Photo: Tom Williams/CQ-Roll Call, Inc. via Getty Images)
Democrats Bankrolled by Big Pharma Are Refusing to Back Covid Vaccine Patent Waiver
The top Democratic recipients of Big Pharma cash in Congress are echoing industry talking points in opposition to a push to suspend key intellectual property protections.
May 04, 2021
The leading Democratic recipients of pharmaceutical industry cash in Congress are refusing to endorse calls for a temporary suspension of patents for coronavirus vaccines and therapeutics, an indication of Big Pharma's influence as it lobbies aggressively in Washington and elsewhere to maintain monopoly control over production.
HuffPost's Daniel Marans reported late Monday that 110 House Democrats have signed on to a letter--led by Rep. Jan Schakowsky (D-Ill.)--calling on President Joe Biden to support India and South Africa's proposed vaccine patent waiver at the World Trade Organization (WTO), which is set to consider the idea again this week. The letter is set to be unveiled on Tuesday.
"Lives around the world depend on this waiver... it's time to do the only humane thing."
--Rep. Ilhan Omar
Citing the latest campaign finance data from the Center for Responsive Politics, Marans noted that "none of the nine House Democrats among Congress' top 25 recipients of donations from pharmaceutical industry PACs in the 2020 election cycle have signed the letter."
"Democratic Reps. Scott Peters (Calif.) and Ron Kind (Wis.)--Nos. 7 and 19, respectively, on the top 25 list--have actually solicited support for another letter to Biden asking him to not waive the intellectual property rules," Marans pointed out.
In addition to Peters and Kind, the other top House Democratic recipients of pharmaceutical industry cash during the 2020 campaign cycle were Reps. Frank Pallone Jr. (N.J.), Richard Neal (Mass.), Anna Eshoo (Calif.), Robin Kelly (Ill.), Brad Schneider (Ill.), Kurt Schrader (Ore.), and Raul Ruiz (Calif.).
Sen. Chris Coons (D-Del.), the top recipient of pharma PAC money among Senate Democrats, has refused to join Sen. Bernie Sanders (I-Vt.) and nine other colleagues in urging Biden to endorse the patent waiver, which would lift a key legal barrier preventing generic manufacturers from mass-producing vaccines for the developing world.
During a virtual event last week, Coons invoked the January 6 insurrection to justify his opposition to temporarily suspending restrictive intellectual property (IP) protections and echoed pharmaceutical industry warnings that the proposed waiver would harm the United States' global competitiveness.
Other Democratic opponents of the patent waiver have similarly framed the issue in ways that closely resemble pharmaceutical industry messaging, as Marans reported Monday.
"A spokesperson for Rep. Robin Kelly of Illinois (No. 17) provided a statement that mirrored what the pharmaceutical industry itself has been saying in opposition to the temporary waiver: That it would not alleviate the current shortage of vaccines," Marans noted.
"It is not clear that the currently proposed broad TRIPS waiver is the fastest method to accomplish this, given manufacturing intricacies and access to raw materials," spokesperson Rachel Kingery said. "Congresswoman Kelly believes U.S. companies should step up domestic production, assist other nations in the development of effective Covid-19 vaccinations, and increase funding to COVAX to protect global health."
While acknowledging that a patent waiver would not be sufficient in itself, experts have disputed pharmaceutical industry talking points that try to divert attention way from IP protections by blaming other factors for production shortages and massively unequal global distribution, such as lack of technical know-how and inadequate manufacturing capacity in developing countries.
"Many people are saying, 'Won't they need the secret recipe?' That's not necessarily the case," Tahir Amin, a founder of the nonprofit Initiative for Medicines, Access, and Knowledge, told the New York Times on Monday. "There are companies that feel they can go it alone, provided they don't have to look over their shoulder and feel like they are going to take someone's intellectual property."
And as The Interceptreported last week, "Factory owners around the globe, from Bangladesh to Canada, have said they stand ready to retrofit facilities and move forward with vaccine production if given the chance."
"Abdul Muktadir, chair and managing director of Incepta, a pharmaceutical firm based in Dhaka, Bangladesh, has told reporters that his firm has the capacity to fill vials for 600 million to 800 million doses of vaccine per year. He has reportedly reached out to Moderna, Johnson & Johnson, and Novavax," The Intercept noted. "Other firms in South Korea and Pakistan have also reportedly expressed an interest in producing vaccines or vaccine components."
\u201c**\u201cAbsolutely...This is the only humane thing in the world to do.\u201d\n\nLives around the world depend on this waiver @POTUS, it\u2019s time to do the only humane thing.\u201d— Ilhan Omar (@Ilhan Omar) 1620091025
On Wednesday and Thursday, WTO member nations will meet to discuss the patent waiver as the Biden administration privately debates whether to throw U.S. support behind the idea, which rich nations have blocked for months.
Dr. Anthony Fauci, Biden's top medical adviser on the Covid-19 pandemic, told the Times in an interview Monday that he "always respect[s] the needs of the companies to protect their interests to keep them in business, but we can't do it completely at the expense of not allowing vaccine that's lifesaving to get to the people that need it."
"You can't have people throughout the world dying because they don't have access to a product that rich people have access to," Fauci added.
\u201cThere should not be a debate here: by not waiving patents and transferring technology, we are putting the financial prerogatives of drug firms above the value of an enormous number of lives worldwide. https://t.co/SLht2xSbVT\u201d— Adam W Gaffney (@Adam W Gaffney) 1620124760
Led by the Free the Vaccine coalition, activists plan to march on the National Mall in Washington, D.C. on Wednesday to demand that Biden and other world leaders to end their opposition to the patent waiver and provide all of the resources necessary to ensure vaccine access in developing countries.
"Millions in the Global South will not get Covid-19 vaccines until 2024," the coalition says on its website. "The Biden administration has an opportunity to make vaccines available by supporting the TRIPS Waiver at the World Trade Organization, as proposed by India and South Africa. Furthermore, the U.S. can and should invest money in scaling up global vaccine manufacturing."
Lori Wallach, director of Public Citizen's Global Trade Watch toldHuffPost Monday that "the greed of pharma means that they are effectively blocking the manufacture of the necessary supply."
"Biden is getting quite good marks--even from a lot of Republicans--about how he's taken on Covid," Wallach said. "All of that positivity and the health gains could be lost if they're not paying attention and a vaccine-resistant variant ends up brewing someplace else, inevitably spreading worldwide and we all end up on lockdown again."
An Unconstitutional Rampage
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
big pharmacampaign financecoronaviruscorporate powerdemocratic partyinequalitypublic healthus congress
The leading Democratic recipients of pharmaceutical industry cash in Congress are refusing to endorse calls for a temporary suspension of patents for coronavirus vaccines and therapeutics, an indication of Big Pharma's influence as it lobbies aggressively in Washington and elsewhere to maintain monopoly control over production.
HuffPost's Daniel Marans reported late Monday that 110 House Democrats have signed on to a letter--led by Rep. Jan Schakowsky (D-Ill.)--calling on President Joe Biden to support India and South Africa's proposed vaccine patent waiver at the World Trade Organization (WTO), which is set to consider the idea again this week. The letter is set to be unveiled on Tuesday.
"Lives around the world depend on this waiver... it's time to do the only humane thing."
--Rep. Ilhan Omar
Citing the latest campaign finance data from the Center for Responsive Politics, Marans noted that "none of the nine House Democrats among Congress' top 25 recipients of donations from pharmaceutical industry PACs in the 2020 election cycle have signed the letter."
"Democratic Reps. Scott Peters (Calif.) and Ron Kind (Wis.)--Nos. 7 and 19, respectively, on the top 25 list--have actually solicited support for another letter to Biden asking him to not waive the intellectual property rules," Marans pointed out.
In addition to Peters and Kind, the other top House Democratic recipients of pharmaceutical industry cash during the 2020 campaign cycle were Reps. Frank Pallone Jr. (N.J.), Richard Neal (Mass.), Anna Eshoo (Calif.), Robin Kelly (Ill.), Brad Schneider (Ill.), Kurt Schrader (Ore.), and Raul Ruiz (Calif.).
Sen. Chris Coons (D-Del.), the top recipient of pharma PAC money among Senate Democrats, has refused to join Sen. Bernie Sanders (I-Vt.) and nine other colleagues in urging Biden to endorse the patent waiver, which would lift a key legal barrier preventing generic manufacturers from mass-producing vaccines for the developing world.
During a virtual event last week, Coons invoked the January 6 insurrection to justify his opposition to temporarily suspending restrictive intellectual property (IP) protections and echoed pharmaceutical industry warnings that the proposed waiver would harm the United States' global competitiveness.
Other Democratic opponents of the patent waiver have similarly framed the issue in ways that closely resemble pharmaceutical industry messaging, as Marans reported Monday.
"A spokesperson for Rep. Robin Kelly of Illinois (No. 17) provided a statement that mirrored what the pharmaceutical industry itself has been saying in opposition to the temporary waiver: That it would not alleviate the current shortage of vaccines," Marans noted.
"It is not clear that the currently proposed broad TRIPS waiver is the fastest method to accomplish this, given manufacturing intricacies and access to raw materials," spokesperson Rachel Kingery said. "Congresswoman Kelly believes U.S. companies should step up domestic production, assist other nations in the development of effective Covid-19 vaccinations, and increase funding to COVAX to protect global health."
While acknowledging that a patent waiver would not be sufficient in itself, experts have disputed pharmaceutical industry talking points that try to divert attention way from IP protections by blaming other factors for production shortages and massively unequal global distribution, such as lack of technical know-how and inadequate manufacturing capacity in developing countries.
"Many people are saying, 'Won't they need the secret recipe?' That's not necessarily the case," Tahir Amin, a founder of the nonprofit Initiative for Medicines, Access, and Knowledge, told the New York Times on Monday. "There are companies that feel they can go it alone, provided they don't have to look over their shoulder and feel like they are going to take someone's intellectual property."
And as The Interceptreported last week, "Factory owners around the globe, from Bangladesh to Canada, have said they stand ready to retrofit facilities and move forward with vaccine production if given the chance."
"Abdul Muktadir, chair and managing director of Incepta, a pharmaceutical firm based in Dhaka, Bangladesh, has told reporters that his firm has the capacity to fill vials for 600 million to 800 million doses of vaccine per year. He has reportedly reached out to Moderna, Johnson & Johnson, and Novavax," The Intercept noted. "Other firms in South Korea and Pakistan have also reportedly expressed an interest in producing vaccines or vaccine components."
\u201c**\u201cAbsolutely...This is the only humane thing in the world to do.\u201d\n\nLives around the world depend on this waiver @POTUS, it\u2019s time to do the only humane thing.\u201d— Ilhan Omar (@Ilhan Omar) 1620091025
On Wednesday and Thursday, WTO member nations will meet to discuss the patent waiver as the Biden administration privately debates whether to throw U.S. support behind the idea, which rich nations have blocked for months.
Dr. Anthony Fauci, Biden's top medical adviser on the Covid-19 pandemic, told the Times in an interview Monday that he "always respect[s] the needs of the companies to protect their interests to keep them in business, but we can't do it completely at the expense of not allowing vaccine that's lifesaving to get to the people that need it."
"You can't have people throughout the world dying because they don't have access to a product that rich people have access to," Fauci added.
\u201cThere should not be a debate here: by not waiving patents and transferring technology, we are putting the financial prerogatives of drug firms above the value of an enormous number of lives worldwide. https://t.co/SLht2xSbVT\u201d— Adam W Gaffney (@Adam W Gaffney) 1620124760
Led by the Free the Vaccine coalition, activists plan to march on the National Mall in Washington, D.C. on Wednesday to demand that Biden and other world leaders to end their opposition to the patent waiver and provide all of the resources necessary to ensure vaccine access in developing countries.
"Millions in the Global South will not get Covid-19 vaccines until 2024," the coalition says on its website. "The Biden administration has an opportunity to make vaccines available by supporting the TRIPS Waiver at the World Trade Organization, as proposed by India and South Africa. Furthermore, the U.S. can and should invest money in scaling up global vaccine manufacturing."
Lori Wallach, director of Public Citizen's Global Trade Watch toldHuffPost Monday that "the greed of pharma means that they are effectively blocking the manufacture of the necessary supply."
"Biden is getting quite good marks--even from a lot of Republicans--about how he's taken on Covid," Wallach said. "All of that positivity and the health gains could be lost if they're not paying attention and a vaccine-resistant variant ends up brewing someplace else, inevitably spreading worldwide and we all end up on lockdown again."
The leading Democratic recipients of pharmaceutical industry cash in Congress are refusing to endorse calls for a temporary suspension of patents for coronavirus vaccines and therapeutics, an indication of Big Pharma's influence as it lobbies aggressively in Washington and elsewhere to maintain monopoly control over production.
HuffPost's Daniel Marans reported late Monday that 110 House Democrats have signed on to a letter--led by Rep. Jan Schakowsky (D-Ill.)--calling on President Joe Biden to support India and South Africa's proposed vaccine patent waiver at the World Trade Organization (WTO), which is set to consider the idea again this week. The letter is set to be unveiled on Tuesday.
"Lives around the world depend on this waiver... it's time to do the only humane thing."
--Rep. Ilhan Omar
Citing the latest campaign finance data from the Center for Responsive Politics, Marans noted that "none of the nine House Democrats among Congress' top 25 recipients of donations from pharmaceutical industry PACs in the 2020 election cycle have signed the letter."
"Democratic Reps. Scott Peters (Calif.) and Ron Kind (Wis.)--Nos. 7 and 19, respectively, on the top 25 list--have actually solicited support for another letter to Biden asking him to not waive the intellectual property rules," Marans pointed out.
In addition to Peters and Kind, the other top House Democratic recipients of pharmaceutical industry cash during the 2020 campaign cycle were Reps. Frank Pallone Jr. (N.J.), Richard Neal (Mass.), Anna Eshoo (Calif.), Robin Kelly (Ill.), Brad Schneider (Ill.), Kurt Schrader (Ore.), and Raul Ruiz (Calif.).
Sen. Chris Coons (D-Del.), the top recipient of pharma PAC money among Senate Democrats, has refused to join Sen. Bernie Sanders (I-Vt.) and nine other colleagues in urging Biden to endorse the patent waiver, which would lift a key legal barrier preventing generic manufacturers from mass-producing vaccines for the developing world.
During a virtual event last week, Coons invoked the January 6 insurrection to justify his opposition to temporarily suspending restrictive intellectual property (IP) protections and echoed pharmaceutical industry warnings that the proposed waiver would harm the United States' global competitiveness.
Other Democratic opponents of the patent waiver have similarly framed the issue in ways that closely resemble pharmaceutical industry messaging, as Marans reported Monday.
"A spokesperson for Rep. Robin Kelly of Illinois (No. 17) provided a statement that mirrored what the pharmaceutical industry itself has been saying in opposition to the temporary waiver: That it would not alleviate the current shortage of vaccines," Marans noted.
"It is not clear that the currently proposed broad TRIPS waiver is the fastest method to accomplish this, given manufacturing intricacies and access to raw materials," spokesperson Rachel Kingery said. "Congresswoman Kelly believes U.S. companies should step up domestic production, assist other nations in the development of effective Covid-19 vaccinations, and increase funding to COVAX to protect global health."
While acknowledging that a patent waiver would not be sufficient in itself, experts have disputed pharmaceutical industry talking points that try to divert attention way from IP protections by blaming other factors for production shortages and massively unequal global distribution, such as lack of technical know-how and inadequate manufacturing capacity in developing countries.
"Many people are saying, 'Won't they need the secret recipe?' That's not necessarily the case," Tahir Amin, a founder of the nonprofit Initiative for Medicines, Access, and Knowledge, told the New York Times on Monday. "There are companies that feel they can go it alone, provided they don't have to look over their shoulder and feel like they are going to take someone's intellectual property."
And as The Interceptreported last week, "Factory owners around the globe, from Bangladesh to Canada, have said they stand ready to retrofit facilities and move forward with vaccine production if given the chance."
"Abdul Muktadir, chair and managing director of Incepta, a pharmaceutical firm based in Dhaka, Bangladesh, has told reporters that his firm has the capacity to fill vials for 600 million to 800 million doses of vaccine per year. He has reportedly reached out to Moderna, Johnson & Johnson, and Novavax," The Intercept noted. "Other firms in South Korea and Pakistan have also reportedly expressed an interest in producing vaccines or vaccine components."
\u201c**\u201cAbsolutely...This is the only humane thing in the world to do.\u201d\n\nLives around the world depend on this waiver @POTUS, it\u2019s time to do the only humane thing.\u201d— Ilhan Omar (@Ilhan Omar) 1620091025
On Wednesday and Thursday, WTO member nations will meet to discuss the patent waiver as the Biden administration privately debates whether to throw U.S. support behind the idea, which rich nations have blocked for months.
Dr. Anthony Fauci, Biden's top medical adviser on the Covid-19 pandemic, told the Times in an interview Monday that he "always respect[s] the needs of the companies to protect their interests to keep them in business, but we can't do it completely at the expense of not allowing vaccine that's lifesaving to get to the people that need it."
"You can't have people throughout the world dying because they don't have access to a product that rich people have access to," Fauci added.
\u201cThere should not be a debate here: by not waiving patents and transferring technology, we are putting the financial prerogatives of drug firms above the value of an enormous number of lives worldwide. https://t.co/SLht2xSbVT\u201d— Adam W Gaffney (@Adam W Gaffney) 1620124760
Led by the Free the Vaccine coalition, activists plan to march on the National Mall in Washington, D.C. on Wednesday to demand that Biden and other world leaders to end their opposition to the patent waiver and provide all of the resources necessary to ensure vaccine access in developing countries.
"Millions in the Global South will not get Covid-19 vaccines until 2024," the coalition says on its website. "The Biden administration has an opportunity to make vaccines available by supporting the TRIPS Waiver at the World Trade Organization, as proposed by India and South Africa. Furthermore, the U.S. can and should invest money in scaling up global vaccine manufacturing."
Lori Wallach, director of Public Citizen's Global Trade Watch toldHuffPost Monday that "the greed of pharma means that they are effectively blocking the manufacture of the necessary supply."
"Biden is getting quite good marks--even from a lot of Republicans--about how he's taken on Covid," Wallach said. "All of that positivity and the health gains could be lost if they're not paying attention and a vaccine-resistant variant ends up brewing someplace else, inevitably spreading worldwide and we all end up on lockdown again."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.
LATEST NEWS
Columbia Yanks Degrees From Pro-Palestine Protesters Amid Outrage Over Khalil Arrest
The impacted students and graduates are accused of participating in the occupation of a university building that protesters renamed in honor of a child killed by Israeli forces in Gaza.
Mar 13, 2025
As the Trump administration's effort to deport Mahmoud Khalil sparks legal battles and demonstrations, Columbia University announced Thursday that it has revoked degrees from some other pro-Palestinian campus protesters.
A campuswide email reported by The Associated Press and shared on social media by Drop Site News says that "the Columbia University Judicial Board determined findings and issued sanctions to students ranging from multiyear suspensions, temporary degree revocations, and expulsions related to the occupation of Hamilton Hall last spring."
According to both news outlets, the university's email did not say how many students and graduates were impacted by each action.
As part of nationwide protests over the U.S. government and educational institutions' complicity in Israel's assault on the Gaza Strip, Columbia students took over the building last April and renamed it Hind's Hall, in honor of a young Palestinian girl killed by Israeli forces. With support from the university's leadership, New York Police Department officers stormed the campus.
Columbia's new sanctions against protesters were widely condemned on social media. Iowa-based writer Gavin Aronsen quipped, "This is a great PR strategy, come to Columbia where you'll get a solid education as long as you never speak your mind."
News of the university's latest action on Thursday came after over 100 people were arrested outside Trump Tower in New York City during a Jewish-led protest over the government's attempt to deport Khalil, a green-card holder who finished his studies at Columbia in December.
"The Trump administration's outrageous detention of Mahmoud Khalil is designed to sow terror and stop people of conscience from calling for Palestinian freedom," said Ros Petchesky, an 82-year-old MacArthur fellow and Columbia alumna. "We are Jewish New Yorkers and we remain steadfast in our commitment to Palestinian freedom, to protecting free speech and the right to protest, and to defending immigrants and all under attack by the Trump regime."
Meanwhile, during a Thursday interview with NPR about Khalil's detention, Troy Edgar, deputy homeland security secretary, equated protesting and terrorism.
Judge Orders Trump Administration to Reverse 'Sham' Mass Firing of Federal Workers
"It is a sad day when our government would fire some good employee and say it was based on performance when they know good and well that's a lie."
Mar 13, 2025
A U.S. judge on Thursday ruled that the Trump administration must reinstate thousands of government workers fired from half a dozen federal agencies based on the "lie" that their performance warranted termination.
U.S. District Judge for the Northern District of California William Alsup—an appointee of former President Bill Clinton—granted a preliminary injunction supporting a temporary restraining order against the Office of Personnel Management (OPM) and acting Director Charles Ezell on the grounds that the mass firing of probationary federal employees is "unlawful" because the agency lacked the authority for the move.
Alsup—who last month also found the OPM firings illegal—ordered the Trump administration to immediately reinstate all probationary employees terminated from the departments of Agriculture, Defense, Energy, Interior, Treasury, and Veterans Affairs.
"The reason that OPM wanted to put this based on performance was at least in part in my judgment a gimmick to avoid the Reductions in Force (RIF) Act, because the law always allows you to fire somebody for performance," Alsup said, referring the process used by federal agencies reduce the size of their workforce during reorganizations or budget cuts.
Last month, Trump signed an executive order directing Elon Musk's Department of Government Efficiency to institute RIFs across federal agencies as part of a so-called "workforce optimization initiative."
"It is a sad day when our government would fire some good employee and say it was based on performance when they know good and well that's a lie," Alsup wrote. "That should not have been done in our country. It was a sham in order to try to avoid statutory requirements."
While the White House blasted Alsup's ruling as "absurd and unconstitutional" and lodged an appeal, advocates for government workers cheered the decision.
Everett Kelley, national president of the American Federation of Government Employees (AFGE), said in a statement that the union "is pleased with Judge Alsup's order to immediately reinstate tens of thousands of probationary federal employees who were illegally fired from their jobs by an administration hellbent on crippling federal agencies and their work on behalf of the American public."
"We are grateful for these employees and the critical work they do, and AFGE will keep fighting until all federal employees who were unjustly and illegally fired are given their jobs back," Kelley added.
Lee Saunders, president of the American Federation of State, County, and Municipal Employees (AFSCME), said: "Public service workers are the backbone of our communities in every way. Today, we are proud to celebrate the court's decision which orders that fired federal employees must be reinstated and reinforces they cannot be fired without reason."
"This is a big win for all workers, especially AFSCME members of the United Nurses Associations of California and Council 20, who will be able to continue their essential work at the Department of Agriculture, Veterans Affairs Department, and other agencies," Saunders added.
Violet Wulf-Saena, founder and executive director of Climate Resilient Communities—a California-based nonprofit that "brings people together to create local solutions for a healthy planet"—also welcomed Thursday's ruling.
"The mass firing of public service employees is a direct assault on the environmental justice movement and will harm people living in heavily polluted communities," she said. "Today's decision represents a key win for our movement because our lifesaving work cannot proceed without the vital infrastructure and support of our federal employees."
Congressman Raúl Grijalva, Defender of Working People and Planet, Dead at 77
"Rep. Grijalva fought a long and brave battle," his staff said. "He passed away this morning due to complications of his cancer treatments."
Mar 13, 2025
Condolences and remembrances swiftly mounted on Thursday after the staff of U.S. Congressman Raúl Grijalva announced that the Arizona Democrat died at the age of 77, following a fight with lung cancer.
"Rep. Grijalva fought a long and brave battle. He passed away this morning due to complications of his cancer treatments," according to the office of the late congressman, who announced his diagnosis last April.
Grijalva, who represented Arizona's 7th District, was first elected to Congress in 2002. While on Capitol Hill, he rose to leadership roles, including co-chair of the Congressional Progressive Caucus and chair of the House Natural Resources Committee.
"From permanently protecting the Grand Canyon for future generations to strengthening the Affordable Care Act, his proudest moments in Congress have always been guided by community voices," Grijalva's staff said. "He led the charge for historic investments in climate action, port of entry modernization, permanent funding for land and water conservation programs, access to healthcare for tribal communities and the uninsured, fairness for immigrant families and Dreamers, student loan forgiveness, stronger protections for farmers and workers exposed to extreme heat, early childhood education expansion, higher standards for tribal consultation, and so much more."
"From Tucson to Nogales and beyond, he worked tirelessly for transformational improvements. Rep. Grijalva pushed for new public parks, childcare centers, healthcare clinics, local businesses, and affordable housing [that] breathed new life into neighborhoods across Southern Arizona. Improvements to our roads, bridges, and streetcar system have improved our daily lives and attracted new businesses and industries to the area," the office added. "Rep. Grijalva's passion was not only for his community, but for preservation of the planet."
Grijalva's colleagues also highlighted key parts of his legacy. Sen. Ed Markey (D-Mass.), a former House member, said that "I am heartbroken by the news of Congressman Raúl Grijalva's passing. For climate justice, economic justice, health justice—Raúl fought fearlessly for change. We served a decade together on the Natural Resources Committee, and I will forever be grateful for his leadership and partnership."
Sen. Bernie Sanders (I-Vt.), who also previously served in the lower chamber, said that "I mourn the death of Rep. Raúl Grijalva, a former colleague of mine and one of the most progressive members of the U.S. House. Raúl was a fighter for working families throughout his entire life. He will be sorely missed."
Congresswoman Alexandria Ocasio-Cortez (D-N.Y.) called his death "a genuinely devastating loss," adding: "Raúl Grijalva stood as one of the biggest champions for working people in all of Congress. His leadership was singular. He mentored generously and was an incredible friend. I will always be grateful for his lifelong courage and commitment."
Rep. Delia Ramirez (D-Ill.) said that "today we lost a dedicated progressive leader in Raúl Grijalva. The son of a bracero, Rep. Grijalva's 12-term commitment to our environment, to immigrant communities, and to his constituents in Tucson enriched this country. His passing is a monumental loss for our caucus and communities."
Congressman Maxwell Alejandro Frost (D-Fla.) wrote: "Wow. This is such a loss for Arizona and our country. Chair Raúl Grijalva has been a champion for progressive change his entire life. From the school board to Congress, his leadership and voice inspired so many. Myself included. Rest in power, Chairman Grijalva."
Rep. Yassamin Ansari (D-Ariz.), elected to Congress in November, said that "I'm devastated to hear of the passing of my colleague Raúl Grijalva. He was a fighter for Arizonans and a champion for Indigenous communities and our planet. We will all miss him dearly. My thoughts are with his family, friends, loved ones, and constituents."
Sen. Ruben Gallego (D-Ariz.), who switched chambers after the last election, said that "Congressman Grijalva was not just my colleague, but my friend. As another Latino working in public service, I can say from experience that he served as a role model to many young people across the Grand Canyon State. He spent his life as a voice for equality."
"In Congress, I was proud to see firsthand his leadership as chairman of the House Natural Resources Committee as he stood up for Arizona's water rights, natural beauty, and tribes," Gallego added. "I am praying for his family during this time of grief, and I hope that they find comfort knowing his legacy is one that will stand tall for generations."
Advocacy group leaders also weighed in, with Kierán Suckling, executive director and founder of the Center for Biological Diversity, calling his death "a heartbreaking, devastating loss for the people of Southern Arizona and everyone around this nation who loves the natural world."
"Raúl was a great friend and partner in our fight for clean air and water, our beautiful public lands, and wildlife great and small," Suckling said. "We can all look to him as the model of what every member of Congress and every person of dignity and hope should aspire to be."
"From Mexican wolves to spotted owls to the New Mexico meadow jumping mouse, every creature in this country had a friend in Raúl," Suckling added. "He was as fierce as a jaguar, and that's why we called him our Macho G. I'll miss him dearly."
According to KVOA, the NBC affiliate in Tucson, Grijalva's office "will continue providing constituent services during the special election" to fill his seat.
Grijalva's death follows that of Congressman Sylvester Turner (D-Texas), who died on March 5. His seat will also need to be filled by a special election.
Most Popular
We cover the issues the corporate media never will.
Please support our journalism.